Skip to main content

Fulgent Genetics, Inc.

FLGT
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001674930

In the last 90 days, Fulgent Genetics, Inc. insiders filed 0 open-market purchases and 4 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $321.8M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Fulgent Genetics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
183
+11 vs. Q2 2024
Shares held
16.1M
+4.75M (+41.8%) vs. Q2 2024
Total value
$349.6M
+$127.0M (+57.0%) vs. Q2 2024
New holders
33
48 more added
Sold out
22
58 more reduced

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FLGT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 183 institutions
Q1 2021: 256 institutionsQ2 2021: 254 institutionsQ3 2021: 269 institutionsQ4 2021: 299 institutionsQ1 2022: 275 institutionsQ2 2022: 263 institutionsQ3 2022: 235 institutionsQ4 2022: 224 institutionsQ1 2023: 216 institutionsQ2 2023: 214 institutionsQ3 2023: 201 institutionsQ4 2023: 197 institutionsQ1 2024: 180 institutionsQ2 2024: 174 institutionsQ3 2024: 183 institutionsQ4 2024: 189 institutionsQ1 2025: 177 institutionsQ2 2025: 168 institutionsQ3 2025: 163 institutionsQ4 2025: 179 institutionsQ1 2026: 158 institutionsQ2 2026: 141 institutions
Value heldQ3 2024: $349.6M
Q1 2021: $973.5MQ2 2021: $986.4MQ3 2021: $1.02BQ4 2021: $1.13BQ1 2022: $758.4MQ2 2022: $710.8MQ3 2022: $506.9MQ4 2022: $391.2MQ1 2023: $422.8MQ2 2023: $514.8MQ3 2023: $380.5MQ4 2023: $413.6MQ1 2024: $322.2MQ2 2024: $299.6MQ3 2024: $349.6MQ4 2024: $314.3MQ1 2025: $275.8MQ2 2025: $323.2MQ3 2025: $389.3MQ4 2025: $468.9MQ1 2026: $277.7MQ2 2026: $321.8M
Institutions holding FLGT and their total value by quarter
QuarterHoldersValue
Q2 2026141$321.8M
Q1 2026158$277.7M
Q4 2025179$468.9M
Q3 2025163$389.3M
Q2 2025168$323.2M
Q1 2025177$275.8M
Q4 2024189$314.3M
Q3 2024183$349.6M
Q2 2024174$299.6M
Q1 2024180$322.2M
Q4 2023197$413.6M
Q3 2023201$380.5M
Q2 2023214$514.8M
Q1 2023216$422.8M
Q4 2022224$391.2M
Q3 2022235$506.9M
Q2 2022263$710.8M
Q1 2022275$758.4M
Q4 2021299$1.13B
Q3 2021269$1.02B
Q2 2021254$986.4M
Q1 2021256$973.5M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Fulgent Genetics, Inc.; share changes are against Q2 2024.

Institutions holding FLGT in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Quarry LP0$00.00%−93−100.0%Sold out
Headlands Technologies LLC0$00.00%−50−100.0%Sold out
Innealta Capital, LLC0$00.00%−24−100.0%Sold out
Tyler-Stone Wealth Management0$00.00%−13−100.0%Sold out
Assetmark, Inc0$00.00%−8−100.0%Sold out
BlackRock Inc.––––Not filed
Benjamin F. Edwards & Company, Inc.––––Not filed